Federal Circuit to Review High-Stakes Trade Secrets and Pharmaceutical License Disputes in June

In June, the Federal Circuit is poised to tackle notable cases, including an effort to resurrect a $64 million trade secrets judgment against Goodyear. This case seeks not only revival but also an expansion of the previously dismissed judgment. In another significant matter, a dispute between pharmaceutical companies Acorda and Alkermes will be heard. This case explores the conditions under which licensees paying royalties on expired patents can seek refunds through arbitration. Further insights into these legal disputes can be found in the detailed coverage provided by Law360.